FRI0285 Initial Adalimumab plus Methotrexate Treatment Prevents Joint Destruction Irrespective of Treatment Duration in Japanese Patients with Early Rheumatoid Arthritis: Post-Hoc Analysis of HOPEFUL 1 and 2 Studies

Abstract

BackgroundInformation about the most effective use of adalimumab (ADA) to prevent joint destruction in Japanese patients with early rheumatoid arthritis (RA) is unavailable.ObjectivesTo evaluate possible time to initiate ADA and...